User:Mark Macbeth/Sandbox2: Difference between revisions
Mark Macbeth (talk | contribs) No edit summary |
Mark Macbeth (talk | contribs) No edit summary |
||
Line 18: | Line 18: | ||
=== Alternative Splicing Pathways === | === Alternative Splicing Pathways === | ||
[[Image:Sxl mechanism alternativesplicing figure version2.jpg|300px|left|thumb| '''Figure 3.''' 2-dimensional representation of alternative splicing repression by Sxl on the ''tra'' and ''msl-2'' genes.]] | [[Image:Sxl mechanism alternativesplicing figure version2.jpg|300px|left|thumb| '''Figure 3.''' 2-dimensional representation of alternative splicing repression by Sxl on the ''tra'' and ''msl-2'' genes.]] | ||
The alternative splicing pathways of Sxl differ, but both involve repression at the 3' splice site<ref name="Handa"/><ref name="Black">. The ''tra'' expression pathway only involves the 3' splice site, while the ''msl-2'' pathway involves both the 3' splice site and the 5' splice site. Both mechanisms cause U2AF binding downstream with lower affinity (Fig. 3)<ref name="Black"/>. U2AF is a more general splicing factor than Sxl, and prefers cytidine-containing poly-uridine pre-mRNA sequences, so Sxl binds to the guanosine-containing pre-mRNA with a 10<sup>4</sup>-fold greater affinity<ref name="Handa"/>. | The alternative splicing pathways of Sxl differ, but both involve repression at the 3' splice site<ref name="Handa"/><ref name="Black"/>. The ''tra'' expression pathway only involves the 3' splice site, while the ''msl-2'' pathway involves both the 3' splice site and the 5' splice site. Both mechanisms cause U2AF binding downstream with lower affinity (Fig. 3)<ref name="Black"/>. U2AF is a more general splicing factor than Sxl, and prefers cytidine-containing poly-uridine pre-mRNA sequences, so Sxl binds to the guanosine-containing pre-mRNA with a 10<sup>4</sup>-fold greater affinity<ref name="Handa"/>. | ||
=== Autoregulation === | === Autoregulation === |